NDC 73028-401-01 - Hydrocortisone Acetate Pramoxine Hydrochloride
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 73028-401
- Requested NDC
- 73028-401-01
- Package NDCs from labels
- 73028-401-01, 73028-401-12
- Manufacturer
- Pageview Pharmaceuticals
- Effective date
- 2022-02-01
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Hydrocortisone Acetate Pramoxine Hydrochloride - Pageview Pharmaceuticals | Pageview Pharmaceuticals | 2022-02-01 | HUMAN PRESCRIPTION DRUG LABEL |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 73028-401-12 | 2024-01-30 | C162847 | 48780-1 | 1030e365-320c-111a-e063-dadaa90a10e2 | Hydrocortisone Acetate 25 mg and Pramoxine Hydrochloride 18 mg Suppositories |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 73028-401-01 | Hydrocortisone Acetate Pramoxine Hydrochloride | 6 in 1 BLISTER PACK | SUPPOSITORY | 6 | 1 | |
| 73028-401-12 | Hydrocortisone Acetate Pramoxine Hydrochloride | 2 in 1 BOX | SUPPOSITORY | 2 | 1 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 73028-401 | HYDROCORTISONE ACETATE PRAMOXINE HYDROCHLORIDE (HYDROCORTISONE ACETATE AND PRAMOXINE HYDROCHLORIDE) SUPPOSITORY [PAGEVIEW PHARMACEUTICALS] | 1 | Legacy NDC, 2 package rows | 20220202_ac9617e7-0487-4ec8-8714-edcf967e9e50.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 73028-401-01 | EA - Each | 73028-401 | b4bc1959-7f46-4b1b-a359-ea5f16932075 | 1 | 2025-06-13 |
| 73028-401-12 | EA - Each | 73028-401 | 168ffd51-64a7-4195-9e85-42d12c1cc7f4 | 1 | 2022-04-06 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| HYDROCORTISONE ACETATE | HYDROCORTISONE ACETATE | Nivagen Pharmaceuticals, Inc. | 7743779d-1e42-4b23-bde5-0d77fe95bb2b | 2023-08-28 | Adverse reactions | 3X7931PO74 |
| hydrocortisone acetate pramoxine hcl | HYDROCORTISONE ACETATE PRAMOXINE HCL | Bryant Ranch Prepack | 0c28458a-cc56-4eea-89aa-d60659bd9568 | 2023-08-17 | Adverse reactions | 88AYB867L5 3X7931PO74 |
| Quality Choice Anti-itch Medicated | CALAMINE AND PRAMOXINE HYDROCHLORIDE | CHAIN DRUG MARKETING ASSOCIATION INC | 5e07f26f-cfb6-57f9-e053-2991aa0a2008 | 2023-08-02 | Warnings | 88AYB867L5 |
| Hydrocortisone Acetate Pramoxine Hcl | HYDROCORTISONE ACETATE PRAMOXINE HCL | Bryant Ranch Prepack | 2f036f41-93b9-4653-b24b-6fadf6fae4e4 | 2023-07-18 | Adverse reactions | 88AYB867L5 3X7931PO74 |
| Hydrocortisone Acetate Pramoxine Hcl | HYDROCORTISONE ACETATE PRAMOXINE HCL | Bryant Ranch Prepack | c79ca385-5fff-4d86-a8b2-098d3e0aa8fa | 2023-07-18 | Adverse reactions | 88AYB867L5 3X7931PO74 |
| Hydrocortisone Acetate Pramoxine Hcl | HYDROCORTISONE ACETATE PRAMOXINE HCL | Bryant Ranch Prepack | 79fae74b-bef2-4e13-a2e9-da68747951eb | 2023-07-18 | Adverse reactions | 88AYB867L5 3X7931PO74 |
| hydrocortisone acetate pramoxine HCl | HYDROCORTISONE ACETATE, PRAMOXINE HCL | Bryant Ranch Prepack | 2c74c1c8-91c7-4468-9b1a-721783431196 | 2023-07-18 | Adverse reactions | 88AYB867L5 3X7931PO74 |
| hydrocortisone acetate pramoxine HCl | HYDROCORTISONE ACETATE, PRAMOXINE HCL | Bryant Ranch Prepack | 1436a6cb-5fa1-41a6-87af-dfbaf0ab2e5b | 2023-07-18 | Adverse reactions | 88AYB867L5 3X7931PO74 |
| hydrocortisone acetate pramoxine hcl | HYDROCORTISONE ACETATE PRAMOXINE HCL | Bryant Ranch Prepack | 3c5e1833-9908-4e4f-bdf2-7a28c14a585c | 2023-07-18 | Adverse reactions | 88AYB867L5 3X7931PO74 |
| Hydrocortisone Acetate | HYDROCORTISONE ACETATE | QUAGEN PHARMACEUTICALS LLC | 60dce400-1138-4781-b621-1774c0dbb64a | 2023-05-17 | Adverse reactions | 3X7931PO74 |
| Hydrocortisone Acetate | HYDROCORTISONE ACETATE | A-S Medication Solutions | 03321951-e338-4955-8622-0f5ea29c6cd9 | 2023-01-18 | Adverse reactions | 3X7931PO74 |
| Radiaura Skin Recovery | LIDOCAINE HCL - HYDROCORTISONE ACETATE | PureTek Corporation | c9502692-674d-e53f-e053-2a95a90a74b3 | 2023-01-11 | Warnings, Adverse reactions | 3X7931PO74 |
| hydrocortisone acetate pramoxine HCl | HYDROCORTISONE ACETATE, PRAMOXINE HCL | Padagis Israel Pharmaceuticals Ltd | 982f0862-2be8-4a65-8b61-8f3a95ab5951 | 2022-05-31 | Adverse reactions | 88AYB867L5 3X7931PO74 |
| Hydrocortisone Acetate Pramoxine Hcl | HYDROCORTISONE ACETATE PRAMOXINE HCL | Padagis Israel Pharmaceuticals Ltd | 87a4c494-56f9-48f6-8592-d610c507a4fc | 2022-05-31 | Adverse reactions | 88AYB867L5 3X7931PO74 |
| Hydrocortisone Acetate | HYDROCORTISONE ACETATE | Padagis US LLC | 2fdb9940-6da8-49b0-a236-9817943f7a4b | 2022-05-31 | Adverse reactions | 3X7931PO74 |
| hydrocortisone acetate pramoxine hcl | HYDROCORTISONE ACETATE PRAMOXINE HCL | Padagis Israel Pharmaceuticals Ltd | 9eea5875-d153-4bba-aee2-b1d1cd8b5e57 | 2022-05-31 | Adverse reactions | 88AYB867L5 3X7931PO74 |
| Hydrocortisone Acetate | HYDROCORTISONE ACETATE | APNAR PHARMA LP | cb60f2a6-8bab-c0f9-e053-2a95a90a422a | 2022-03-16 | Adverse reactions | 3X7931PO74 |
| d4f8a1fa-dcd1-4363-8df2-da07a5c162a6 | ac9617e7-0487-4ec8-8714-edcf967e9e50 | 2022-02-01 | Adverse reactions | d4f8a1fa-dcd1-4363-8df2-da07a5c162a6 ac9617e7-0487-4ec8-8714-edcf967e9e50 | ||
| Cuadriderma | BACITRACIN ZINC, POLYMYXIN B SULFATE, NEOMYCIN SULFATE, AND PRAMOXINE HYDROCHLORIDE | ProMex LLC | 4fa99b96-ab4b-4523-82bc-343dbaf39fb6 | 2022-01-25 | Warnings | 88AYB867L5 |
| Hydrocortisone Acetate | HYDROCORTISONE ACETATE | Patrin Pharma Inc. | 7c1d2c8c-26e2-432f-b983-505f259665a9 | 2021-12-22 | Adverse reactions | 3X7931PO74 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.